Man in Hong Kong reinfected with COVID-19 four months after initially contracting the virus
August 25, 2020Manufacturing and Production COVID-19, coronavirus, infection
A man in Hong Kong has been reinfected with the coronavirus, stoking fears that immunity to the virus may be …
US approves new generic to treat people suffering from respiratory conditions
August 25, 2020Manufacturing and Production asthma, inhaler
The FDA has granted Lupin Ltd approval for their generic version of ProAir, which is used to prevent asthma symptoms …
AstraZeneca begins antibody COVID-19 treatment trial in the UK
August 25, 2020Manufacturing and Production Vaccine, coronavirus
AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus. The …
AstraZeneca reaches deal with RenalytixAI to develop medicine strategies for a variety of diseases
August 24, 2020Sales and Marketing AI, chronic disease
AstraZeneca and RenalytixAI have agreed a deal to develop joint precision medicine strategies for cardiovascular, renal and metabolic diseases. The …
China’s ‘insect’ vaccine for COVID-19 approved for human testing
August 24, 2020Sales and Marketing COVID, Vaccine, coronavirus
China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect …
Gilead says FDA could expand eligibility of coronavirus patients for remdesivir
August 24, 2020Sales and Marketing FDA, Gilead
The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.
FDA approves Phase 1 trial for HIV gene therapy
August 24, 2020Sales and Marketing CAR T, CAR T cancer therapies, CAR-T
The FDA has approved a request from American Gene Technologies to begin a clinical study into its HIV gene therapy. …
FDA grants emergency authorisation for coronavirus plasma treatment
August 24, 2020Sales and Marketing COVID-19, FDA, coronavirus
The FDA has issued an Emergency Use Authorization (EUA) for convalescent plasma to treat patients with COVID-19. The regulatory body …
Janssen granted US approval for multiple myeloma drug combination
August 21, 2020Medical Communications
The FDA has approved Genmab and Janssen’s Darzalex (daratumumab) as a treatment for relapsed and refractory multiple myeloma, when combined …
FDA approves Novartis’ MS drug Kesimpta for treating relapsed forms of the disease
August 21, 2020Medical Communications
The FDA has authorised Novartis’ Kesimpta (ofatumumab) for treating patients with relapsing forms of multiple sclerosis (MS), it has been …
NICE recommends combination treatment from Roche for certain lymphoma patients
August 21, 2020Medical Communications FDA, FDA Approval
NICE has moved to recommend Roche’s Polivy (polatuzumab vedotin), when combined with rituximab and bendamustine, for the treatment of diffuse …
AstraZeneca scores Japanese approval for Imfinzi combo in extensive-stage small cell lung cancer
August 21, 2020Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, Japan
AstraZeneca’s Imfinzi (durvalumab) has secured approval in Japan for the treatment of extensive-stage small cell lung cancer when combined with etoposide and …
Top Ten most popular articles on Pharmafile.com this week
August 21, 2020Medical Communications COVID-19, coronavirus
The top 10 news stories this week again focus on coronavirus vaccines and treatments, as professor Alexander Chuchalin has quit …
FDA turns down Gilead’s JAK inhibitor filgotinib in rheumatoid arthritis, endangering 2020 approval hopes
August 20, 2020Research and Development, Sales and Marketing FDA, Gilead, filgotinib
Gilead’s JAK inhibitor filgotinib has been unexpectedly knocked back by the FDA as a therapy to treat moderately to severely …
Mylan secures first FDA approval for generic version of Biogen’s Tecfidera following patent dispute
August 20, 2020Sales and Marketing Biogen, FDA, Mylan, generic, tecfidera
The FDA has approved its first generic of Biogen’s multiple sclerosis (MS) treatment Tecfidera, awarding authorisation to Mylan which is …
FDA delays BioMarin’s gene therapy for haemophilia A
August 20, 2020Research and Development, Sales and Marketing FDA
The FDA has delayed Roctavin, BioMarin’s gene therapy for haemophilia A, by a year to wait for more extensive results, …
Johnson & Johnson seals largest pharmaceutical merger of the year by purchasing Momenta for $6.5 billion
August 20, 2020Business Services, Sales and Marketing Johnson and Johnson, Momenta
Johnson & Johnson is set to buy the Cambridge based Momenta Pharmaceuticals for $6.5 billion, making it the largest pharmaceutical …
Former MP and Labour leadership candidate joins Bristol Myers Squibb
August 20, 2020Business Services Big Pharma, Pfizer
Owen Smith, the former Labour MP and leadership candidate, has joined Bristol Myers Squibb as its UK Government Relations Director. Smith …
MSD unveils plans for $1.3bn central London research centre
August 19, 2020Manufacturing and Production, Research and Development London, MSD, pharma
MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …
Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate
August 19, 2020Research and Development AstraZeneca, Australia, COVID-19, pharma
Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
